By:
On:
In: Fair company, Stock analysis
Tagged:
With: 0 Comments

Several times a year, a Confident Investor must reevaluate the companies in the portfolio. Keeping your money in a stock that no longer qualifies as a “Good” company can end up hurting your investment performance a great deal.  Also, there are a lot of Good Companies so losing the worst of the best is not going to impact the ability to have a balanced portfolio.  Over the coming days, this site will evaluate each stock on the Watch List.

 

Company name NRG Energy, Inc.
Stock ticker NRG
Live stock price [stckqut]NRG[/stckqut]
P/E compared to competitors Good
MANAGEMENT EXECUTION
Employee productivity Good
Sales growth Fair
EPS growth Poor
P/E growth Good
EBIT growth Poor
ANALYSIS
Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $28.18
Target stock price (averages with growth) $26.79
Target stock price (averages with no growth) $21.08
Target stock price (manual assumptions) $24.16

The following company description is from Google Finance: http://www.google.com/finance?q=nrg
NRG Energy, Inc. (NRG) is a wholesale power generation company. It is engaged in the ownership, development, construction and operation of power generation facilities, the transacting in and trading of fuel and transportation services, the trading of energy, capacity and related products in the United States and select international markets, and the supply of electricity and energy services to retail electricity customers in the Texas market. On May 1, 2009, the Company completed the acquisition of Reliant Energy, Inc. (Reliant Energy). On November 20, 2009, NRG, through its subsidiary NRG Solar LLC, acquired FSE Blythe 1, LLC (Blythe Solar) from First Solar, Inc. On November 9, 2009, NRG, through its wholly owned subsidiary, NRG Bluewater Holdings LLC, completed the acquisition of a 100% interest in the subsidiaries of Bluewater Wind LLC. In December 2009, NRG completed its Langford project, a 150 megawatt wind farm located in Tom Green, Irion, and Schleicher Counties, Texas.

 

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in this stock as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns. This company used to be on the Watch List but I am removing it now that it dropped to Fair.

 

By:
On:
In: Good company, Stock analysis
Tagged:
With: 0 Comments

Several times a year, a Confident Investor must reevaluate the companies in the portfolio. Keeping your money in a stock that no longer qualifies as a “Good” company can end up hurting your investment performance a great deal.  Also, there are a lot of Good Companies so losing the worst of the best is not going to impact the ability to have a balanced portfolio.  Over the coming days, this site will evaluate each stock on the Watch List.

 

Company name Image Sensing Systems, Inc.
Stock ticker ISNS
Live stock price [stckqut]ISNS[/stckqut]
P/E compared to competitors Good
MANAGEMENT EXECUTION
Employee productivity Fair
Sales growth Good
EPS growth Good
P/E growth Good
EBIT growth Good
ANALYSIS
Confident Investor Rating Good
Target stock price (TWCA growth scenario) $21
Target stock price (averages with growth) $27.37
Target stock price (averages with no growth) $18.53
Target stock price (manual assumptions) $19.69

The following company description is from Google Finance: http://www.google.com/finance?q=isns
Image Sensing Systems, Inc. develops and markets video and radar image processing products for use in traffic applications, such as intersection control, highway, bridge and tunnel traffic management and traffic data collection. The Company provides software-based, computer-enabled detection (CED) products and solutions for the intelligent transportation systems (ITS) industry. Its family of products is marketed as Autoscope and RTMS. The Company?s technology analyzes signals from sensors and transmits the information to management systems and controllers or directly to users. In June 2010, the Company acquired CitySync Limited.

 

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in this stock.

By:
On:
In: Good company, Stock analysis
Tagged:
With: 0 Comments

Several times a year, a Confident Investor must reevaluate the companies in the portfolio. Keeping your money in a stock that no longer qualifies as a “Good” company can end up hurting your investment performance a great deal.  Also, there are a lot of Good Companies so losing the worst of the best is not going to impact the ability to have a balanced portfolio.  Over the coming days, this site will evaluate each stock on the Watch List.

Company name Alexion Pharmaceuticals, Inc.
Stock ticker ALXN
Live stock price [stckqut]ALXN[/stckqut]
P/E compared to competitors Fair
MANAGEMENT EXECUTION
Employee productivity Good
Sales growth Good
EPS growth Good
P/E growth Good
EBIT growth Good
ANALYSIS
Confident Investor Rating Good
Target stock price (TWCA growth scenario) $145.74
Target stock price (averages with growth) $211.41
Target stock price (averages with no growth) $116.75
Target stock price (manual assumptions) $112.48

The following company description is from Google Finance: http://www.google.com/finance?q=alxn
Alexion Pharmaceuticals, Inc. (Alexion) is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer and autoimmune disorders. Its marketed product Soliris (eculizumab) is a therapy approved for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH). In April 2009 and August 2009, the United States food and drug administration (FDA) and the European Commission (E.C.), respectively, granted Soliris orphan drug designation for the treatment of patients with atypical Hemolytic Uremic Syndrome (aHUS). In December 2009, its Rhode Island manufacturing facility received regulatory approval from the E.C. for the production of Soliris.

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in this stock.

By:
On:
In: Fair company, Stock analysis
Tagged:
With: 0 Comments
Company name Barrick Gold Corporation (USA)
Stock ticker ABX
Live stock price [stckqut]ABX[/stckqut]
P/E compared to competitors Good
MANAGEMENT EXECUTION
Employee productivity Good
Sales growth Good
EPS growth Poor
P/E growth Poor
EBIT growth Poor
ANALYSIS
Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $0.58
Target stock price (averages with growth) $5.55
Target stock price (averages with no growth) $15.4
Target stock price (manual assumptions) $41.8

The following company description is from Google Finance: http://www.google.com/finance?q=abx
Barrick Gold Corporation (Barrick) is engaged the production and sale of gold, as well as related activities, such as exploration and mine development. Barrick also produces copper, and hold interests in oil and gas properties located in Canada. Its producing mines are concentrated in four regional business units: North America, South America, Africa and Australia Pacific. In addition, it has a Capital Projects segment, distinct from its regional business units, to focus on managing projects. On September 17, 2009, the Company completed the acquisition of 50% interest in the Valhalla oil and gas field. On April 22, 2009, it completed the acquisition of the remaining 50% interest in the Williams and David Bell gold mines (Hemlo) in Canada from Teck Resources Ltd., thereby increasing its interest to 100%.


Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in this stock as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns. Jim Cramer interviewed the CEO of this company yesterday and Mr. Cramer seems rather bullish. While this company isn’t a terrible play in gold, this analysis shows that they aren’t incredibly well run and you may want to just stick with the gold ETF [stckqut]GLD[/stckqut] for your precious metal play. I cannot echo Mr. Cramer’s enthusiasm for this company.

By:
On:
In: Fair company, Stock analysis
Tagged:
With: 0 Comments
Company name Varian Medical Systems, Inc.
Stock ticker VAR
Live stock price [stckqut]VAR[/stckqut]
P/E compared to competitors Fair
MANAGEMENT EXECUTION
Employee productivity Fair
Sales growth Fair
EPS growth Good
P/E growth Poor
EBIT growth Good
ANALYSIS
Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $64.98
Target stock price (averages with growth) $86.97
Target stock price (averages with no growth) $73.19
Target stock price (manual assumptions) $68.31

The following company description is from Google Finance: http://www.google.com/finance?q=var
Varian Medical Systems, Inc. is engaged in he design, manufacture, sale and service of equipment and software products for treating cancer with radiotherapy, stereotactic radiosurgery and brachytherapy. It also design, manufacture, sell and service x-ray tubes for original equipment manufacturers; replacement x-ray tubes, and flat panel digital image detectors for filmless x-ray imaging in medical, dental, veterinary, scientific and industrial applications. It designs, manufactures, sells and services linear accelerators, digital image detectors, image processing software and image detection products for security and inspection purposes. It also develops, designs, manufactures, sells and services proton therapy products and systems for cancer treatment. The Company?s products include Oncology Systems and X-ray Products. The Company has two other businesses and its Ginzton Technology Center (GTC) that it reports together under the Other category.


Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in this stock as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.